Why Medical Cannabis Remains Out of Reach in the UK
Despite medical cannabis being legal in the UK since 2018, strict NHS prescribing rules and high private clinic costs mean many patients still struggle to access treatment.
When the UK legalized medical cannabis in 2018, many assumed patients would soon be able to access it much like any other prescription medicine. Fast forward to today, and the reality is rather less celebratory. Medical cannabis is legal—but for many patients, actually getting it can feel like queuing for a bus that never arrives. So why is access still so difficult?
Legal Doesn’t Mean Accessible
The UK changed its laws in November 2018 following high-profile campaigns by families of children with severe epilepsy. Cannabis-based medicinal products were moved into a category that allows specialist doctors to prescribe them.
That sounds straightforward enough. Unfortunately, “legal” and “easy to obtain” are two very different things.
Unlike many U.S. states, the UK never created a broad medical cannabis program with qualifying conditions and licensed dispensaries. Instead, prescriptions are handled through the country’s healthcare system and remain tightly controlled.
The NHS Says “Only in Certain Cases”
For most people, the biggest hurdle is the National Health Service (NHS).
While the NHS does fund a small number of cannabis-based medicines, they are generally reserved for specific conditions where evidence is considered strongest. These include some forms of severe treatment-resistant epilepsy, chemotherapy-induced nausea and vomiting, and spasticity associated with multiple sclerosis.
Even then, patients must usually meet strict eligibility criteria, and cannabis is rarely considered a first-line treatment. In many cases, several conventional therapies must fail before it enters the conversation.
Specialists Hold the Keys
Another obstacle is who can actually prescribe medical cannabis.
General practitioners (GPs)—the family doctors most Britons see first—cannot usually initiate prescriptions for cannabis-based medicinal products. That responsibility typically falls to specialist consultants, adding another layer of referrals, appointments, and waiting times.
If navigating healthcare bureaucracy were an Olympic sport, Britain would probably fancy its chances.
Private Clinics Fill the Gap
Unable to obtain prescriptions through the NHS, many patients turn to private cannabis clinics.
These clinics have expanded rapidly in recent years and can prescribe medical cannabis for a wider range of conditions when clinically appropriate. The catch? Patients pay out of pocket for consultations, follow-up appointments, and the medication itself.
Depending on the treatment plan, costs can reach hundreds of pounds each month, which is hardly an affordable option for everyone.
The Evidence Debate
So why are the rules so strict?
UK health authorities generally require strong clinical evidence before recommending treatments through the NHS. While research on medical cannabis continues to grow, regulators argue that evidence for many conditions is still limited compared with conventional medicines.
Patient advocates counter that this creates a frustrating cycle: limited prescribing makes it harder to gather real-world data, while the lack of data is then used to justify limited prescribing.
Some Patients Return to the Illicit Market
For those unable to qualify for NHS treatment—or unable to afford private care—the legal products may simply be out of reach.
As a result, some patients continue buying cannabis from illicit sources with hopes that it will help them manage chronic pain, anxiety, or other symptoms. Besides creating legal uncertainty, this also raises concerns about product quality, consistency, and patient safety.
A Different Kind of Medical Cannabis System
To American readers, the UK’s approach may seem surprisingly restrictive. Many U.S. medical cannabis programs allow physicians to recommend cannabis for dozens of qualifying conditions, with patients purchasing products from licensed dispensaries.
The UK has taken a much more cautious path. Medical cannabis is legal, but access remains heavily dependent on specialist oversight, strict clinical guidelines, and—quite often—a patient’s ability to pay.
In other words, Britain’s medical cannabis system isn’t defined by whether cannabis is legal. It’s defined by how difficult it is to obtain. And for many patients, that’s the part that matters most.
Read more from Soft Secrets:
S
Stephen Andrews
